English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17933/22952 (78%)
Visitors : 7333866      Online Users : 367
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24475


    Title: The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics
    Authors: Chou, YE;Yang, PJ;Lin, CY;Chen, YY;Chiang, WL;Lin, PX;Huang, ZY;Huang, M;Ho, YC;Yang, SF
    Keywords: prostate cancer;HMGB1;polymorphism
    Date: 2020
    Issue Date: 2022-08-09T08:02:56Z (UTC)
    Publisher: MDPI
    Abstract: Prostate cancer is one of the major cancers of the genitourinary tract. High-mobility group box 1 (HMGB1) was suggested as a promising therapeutic target for prostate cancer. In this study, we aim to elucidate the associations of HMGB1 single nucleotide polymorphisms (SNPs) with prostate cancer susceptibility and clinicopathological characteristics. The HMGB1 SNPs rs1412125, rs2249825, rs1045411, and rs1360485 in 579 prostate cancer patients and 579 cancer-free controls were analyzed with real-time polymerase chain reactions (real-time PCR). All of the data were evaluated with SAS statistical software. Our results showed that the HMGB1 rs1045411 T allele genotype was significantly associated with advanced pathologic T stage (odds ratio (OR) = 1.433, 95% confidence interval (CI) = 1.021-2.012; p = 0.037) and pathologic N1 stage (OR = 2.091, 95% CI = 1.160-3.767; p = 0.012), and the rs1360485 polymorphic CT + TT genotype was associated with pathologic Gleason grade group (4 + 5) (OR = 1.583, 95% CI = 1.017-2.462; p = 0.041), pathologic T stage (3 + 4) (OR = 1.482, 95% CI = 1.061-2.070; p = 0.021), and pathologic N1 stage (OR = 2.131, 95% CI = 1.178-3.852; p = 0.011) compared with their wild-type carriers. In conclusion, our results revealed that the HMGB1 SNPs were associated with the clinical status of prostate cancer. The HMGB1 SNPs may have the potential to predict prostate cancer disease progression.
    URI: http://dx.doi.org/10.3390/ijerph17197247
    https://www.webofscience.com/wos/woscc/full-record/WOS:000586563500001
    https://ir.csmu.edu.tw:8080/handle/310902500/24475
    Relation: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH ,2020 ,v17 ,issue 19
    Appears in Collections:[中山醫學大學研究成果] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML147View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback